Alkylation at the O 6 -position of guanine leads to one of the most significant mutagenic lesions in DNA; O 6 -alkylguanine which has many biological effects. The mutagenicity of this analogue (causes GC to AT transition mutations) as well as cytotoxicity is well documented and its DNA repair is undertaken by O 6 -methylguanine-DNA methyltransferase (MGMT) protein [1]- [3] . The repair mechanism involves an S N 2 process in which the alkyl group is transferred to SH group of the cysteine residue which renders the protein inactive with the regeneration of guanine [4] . Although MGMT performs an important task in the repair of the O 6 -alkylguanine lesions in DNA, it also promotes tumour resistance to certain alkylating agents commonly used in cancer treatment. MGMT is thus of great interest in the field of cancer chemotherapy and treatment because since the most common method used in cancer therapy is DNA alkyalation which works by damaging DNA and induction of cancer cells apoptosis. Since MGMT repairs alkylation damage, its expression therefore counteracts these forms of treatment [5] . Also its high level of expression in certain types of tumour cells negates the therapeutic benefit of the cancer chemotherapy from the alkylated products [6] . Recently ATL proteins (alkyltransferase-like proteins) were discovered which are homologues of alkyltransferases that bind to, but do not de-alkylate DNA containing O 6 -alkylguanine lesions. In most ATL proteins the active site cysteine is substituted by tryptophan [7] .
I. INTRODUCTION
Alkylation at the O 6 -position of guanine leads to one of the most significant mutagenic lesions in DNA; O 6 -alkylguanine which has many biological effects. The mutagenicity of this analogue (causes GC to AT transition mutations) as well as cytotoxicity is well documented and its DNA repair is undertaken by O 6 -methylguanine-DNA methyltransferase (MGMT) protein [1] - [3] . The repair mechanism involves an S N 2 process in which the alkyl group is transferred to SH group of the cysteine residue which renders the protein inactive with the regeneration of guanine [4] . Although MGMT performs an important task in the repair of the O 6 -alkylguanine lesions in DNA, it also promotes tumour resistance to certain alkylating agents commonly used in cancer treatment. MGMT is thus of great interest in the field of cancer chemotherapy and treatment because since the most common method used in cancer therapy is DNA alkyalation which works by damaging DNA and induction of cancer cells apoptosis. Since MGMT repairs alkylation damage, its expression therefore counteracts these forms of treatment [5] . Also its high level of expression in certain types of tumour cells negates the therapeutic benefit of the cancer chemotherapy from the alkylated products [6] . Recently ATL proteins (alkyltransferase-like proteins) were discovered which are homologues of alkyltransferases that bind to, but do not de-alkylate DNA containing O 6 -alkylguanine lesions.
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In most ATL proteins the active site cysteine is substituted by tryptophan [7] .
Different approaches have been taken to target the MGMT in the development of anti-cancer therapy. The success of MGMT depletion depends upon the O 6 -alkylation being the determinant of the cancer cell death. Several attempts to deplete the level of MGMT through the provision of larger doses of alkylating agents or combining multiple agents so that the number of O 6 -alkylguanine adducts in DNA exceeds the number of MGMT molecules were unsuccessful due to the toxicity [8] , [9] . This problem has led to the increasing interest in designing more effective inhibitors of MGMT and understanding the repair reaction process. We have been interested for some time in incorporating tricyclic analogues of O
6
-methylguanine into DNA that may allow covalent cross-linking of such DNA to MGMT or Atl1 (via a suitable mutant). Such complexes will allow structural information to be derived via X-ray crystallography or would provide suitable protein-DNA complexes for identification of protein partners from crude cell lysates.
Prior to Daniels' crystal structure in 2004, all crystal structures of MGMT or related alkyltransferases from other organisms were obtained in the absence of substrate DNA [10] . In 2001, Noll and Clarke described the formation of an MGMT -DNA complex as a result of interstrand cross-links via N 1 ,O 6 -ethanoguanine (1) Fig. 1 [7] . Here we describe chemistry directed to the synthesis of the nucleoside 2.
II. RESULTS AND DISCUSSION
The synthesis of the key intermediate pyrrolo [2, 3-d] pyrimidinone 9 was achieved in seven steps from butane-1, 4-diol (Fig. 3) . Thus, butane-1, 4-diol 3 was monobenzoylated using benzoyl chloride in pyridine and triethylamine to give 4-benzoyloxy-1-butanol 4, in approximately 44% yield. The monobenzoylated product is formed together with a bis-benzoylated diol (40%) and some of the starting material was found unreacted from the TLC of the reaction mixture. The crude product was distilled under reduced pressure and Compound 4 was isolated as colourless oil which solidifies as a white solid at room temperature.
The benzoylated alcohol 4 was oxidised using pyridinium chlorochromate (PCC) in dichloromethane to give a monobenzoylated aldehyde, 4-benzoyloxybutanal 5. Hyflo super cel and silica were added to the reaction mixture at the beginning in order to make the purification easier. The black residue of the PCC was removed through filtration using a column loaded with three layers of sand, hyflo super cel and silica. The column was eluted with dichloromethane and the filtrate was evaporated and the product 5, was obtained as a colourless oil in 92% yield.
Compound 5 was converted into the nitro alcohol 6, by an aldol condensation with nitromethane. The crude product was obtained as an orange-yellow oil which solidified at room temperature. Silica column chromatography afforded the pure nitro alcohol 6, in 39% yield.
The nitro alcohol was subjected to dehydration using methanesulfonyl chloride at 0 o C. The reaction involves forming a mesylate intermediate which allows E2
elimination following a slow addition of dry triethylamine. This led to the formation of an alkene, (E)-5-nitropent-4-enylbenzoate 7 which was used straight away in the next reaction without further purification due to its tendency to polymerise. The Michael addition of the commercially available 2,6-diamino-4-pyrimidinone to nitro olefin 7 in a mixture of water and ethylacetate was performed at 50 o C overnight. The desired Michael-coupled product was obtained as a yellow foam which was recrystallised from 1,4-dioxane.
The pyrrolopyrimidine 9 was obtained in a two-step, one pot reaction via an oxime intermediate. This chemistry is analogous to that previously described for the corresponding benzyl derivatives of compound 8 [12] . The pyrrolopyrimidine 9 was precipitated along with inorganic compounds after acidification, but was poorly soluble in most solvents which complicated its purification. Recrystallisation with 10% aqueous acetonitrile was for some batches acceptable, whilst silica column chromatography was run as the second alternative. Compound 9 eluted from the column with some gummy material which appered to be a triethylammonium salt according to 1 H NMR evidence. Compound 9 was obtained in 50% yield using silica chromatography.
There are a number of different synthetic routes toward achieving the bis-chlorinated nucleobase 11 [13] but the most feasible one is given in Fig. 4 . Debenzoylation was carried out by refluxing compound 9 in 1M NaOH at 50˚C for one hour. The mixture was neutralised with acetic acid and after column chromatography afforded the pure pyrrolopyrimidine alcohol 10 as white solid in 63% yield.
The bis-chlorination was carried out on compound 10 by refluxing with phosphoryl chloride at 80˚C for two hours. The product was purified by silica column chromatography to give a white solid 11 in 20% yield. Compound 9 was found to be insoluble in acetonitrile (usual solvent for glycosylation reaction). Furthermore, the presence of the lactam NH in addtion to the pyrrolic NH could leads to both N1and N4 glycosylated residue. Thus, the benzoyl protected pyrrolopyrimidine 9 was converted into dichloro compound 11. In addition, it was expected that bis-chlorinated nucleoside 13 might proceed intramolecular nucleophilic reaction (upon treatement with a base) which can leads to the cyclisation into the tricyclic nucleoside 2.
Glycosylation of the bis-chlorinated nucleobase 11 was achieved by reaction of its sodium salt with 1-chloro-2-deoxy-3,5-di-O-p-toluoyl-α-D-erythro-pentofura nose (chlorosugar) in anhydrous acetonitrile. 13 Removal of the toluoyl protecting groups was achieved by treatment with a 1:1 mixture of 1M aq. NaOH/1,4-dioxane. TLC analysis showed that compound 14 was obtained after overnight stirring but after 3 days, two nucleosides, the tricyclic nucleoside 2 (R f 0.45 in 10% MeOH/DCM) which is fluorescent under UV and the ring open nucleoside 15 were observed. Purification by silica column chromatography gave compound 2 in 19% yield and 15 in 42% yield (Fig. 5) . In conclusion, synthesis of compound 2 was successfully achieved via the bis-chlorinated intermediate 11. We are currently engaged in incorporating the tricyclic nucleoside into DNA which will be subsequently reported elsewhere.
III. EXPERIMENTAL
Most of the solvents were obtained from Fisher and used without further purification if they were not requested to be anhydrous in the reaction procedure. Pyridine, acetonitrile and triethylamine were dried under reflux from calcium hydride and then distilled and stored over 3Å molecular sieves under Ar. MeOH was dried under reflux from magnesium and iodine, then distilled and stored over 3Å molecular sieves under Ar. N,N-Dimethylformamide and tetrahydrofuran were obtained as an anhydrous solvent from Aldrich. Phosphoryl chloride was freshly distilled just before use. Silica TLC were; A (dichloromethane), B (2% methanol in dichloromethane), C (10% methanol in dichloromethane) and D (20% methanol in dichloromethane). The developed TLC plates were viewed under UV and stained with anisaldehyde. Nuclear Magnetic Resonance (NMR) spectra were run on a Bruker AC-250 spectrometer or AMX-400 spectrometer.
1 H spectra were run at 250.13 MHz or 400.13 MHz and 13 C spectra at 62.83 MHz or 100.61 MHz. All chemical shifts are quoted in ppm relative to tetramethylsilane as an external standard. All coupling counstants are quoted in Hertz. All mass spectra were obtained from the university of sheffield mass spectrometry service.
A. 4-(Benzoyloxy)Butanol (4)
.00 g, 242.3 mmol.) followed by the addition of dichloromethane (33 mL) and cooled to 0 o C in an ice-bath. Benzoyl chloride (16.00 g, 12.8 mL, 110.0 mmol) in dichloromethane (20 mL) was added dropwise and the reaction was left to stir overnight. The solution was diluted with ether (100 mL) and the organic phase was washed with water (3 x 20 mL), sodium bicarbonate solution (3 x 20 mL), dried (MgSO 4 ) and evaporated. The resulting oil was purified by silica column chromatography (eluted with ethyl acetate: hexane 1:1) to obtain a colourless oil (22.10 g, 51%): R f (A), 0. 
B. 4-(Benzoyloxy)Butanal (5)
A solution of 4-benzoyloxybutanol (4) (14.75 g, 76.0 mmol.) in dichloromethane (100 mL) was added in one portion to a solution of a stirred suspension of pyridinium chlorochromate 98% (35.88g, 166.5 mmol.), hyflosuper cel (10 g) and silica (10 g), the pyridinium chlorochromate, hyflosuper cel and silica where well stirred in dichloromethane (200 mL) in an ice-bath before adding the alcohol. After addition the bright orange suspension becomes black. The reaction was left stirring for 3 h. until complete (checked by silica TLC). The solution was separated from the black precipitate by filtration using a column containing three layers; sand, hyflosuper cel and silica. The column was eluted with dichloromethane and the filtrate was evaporated to give a colourless oil (13. 
C. 5-(Benzoyloxy)-1-Nitropentan-2-ol (6)
4-Benzoyloxybutanal 5 (12.90 g, 67.2 mmol.) and nitromethane (4.10 g, 67.2 mmol.) were dissolved in equal volume of ethanol (30 mL each) and cooled in an ice-bath to 0 o C and sodium hydroxide (6 M, 2.8 g in 12 mL water) was added dropwise over 3 h. so that the temperature did not exceed 0 o C. Ice water (50 mL) was then added to the reaction mixture followed by the addition of glacial acetic acid until the precipitated salt was dissolved and the pH was 6. The solution was extracted with ethyl acetate (175 mL) and the organic phase was washed with water (50 mL), then saturated sodium chloride solution (50 mL), then dried (MgSO 4 ) and evaporated to give orange-yellow oil (11.70 g). Purification by silica column chromatography (eluted with dichloromethane) gave a pale-yellow oil which solidifies at room temp. (6.60 
D. (E)-5-Nitropent-4-Enylbenzoate (7)
Methanesulfonyl chloride (2.00 g, 17.7 mmol) was added to stirred solution of 6 (4.50 g, 17.7 mmol) in dry dichloromethane (30 mL) at 0 o C under an argon atmosphere. Dry triethylamine (4.9 mL, 35.4 mmol) was then added via a syringe pump at the rate 5mL h -1 . When the reaction was completed, the mixture was transferred to a separating funnel with dichloromethane (30 mL) and the organic layer was sequentially washed with water (20 mL), 5% HCl (20 mL), 10% Na 2 CO 3 (20 mL) and brine (20 mL). The organic layer was dried (MgSO 4 ) and the solvent removed in vacuo, giving the crude product 7 (2.60 g, 11.1 mmol, 63%) as an orange oil, which was used further without further purification. + .
E. 2,6-Diamino-5-[5-Benzoyloxy-1-Nitropentan-2-yl]Pyri midin-4(3H)-One (8)
A solution of 2,6-diamino-4(3H)-pyrimidinone (5.40 g, 42.6 mmol) in water (60 mL) and alkene 7 (10.00 g, 42.6 mmol) in ethylacetate (60 mL) were mixed and stirred overnight at 65 o C. The organic layer was then washed with water (60 mL), dried (MgSO 4 ) and the solvent removed in vacuo to give a yellow foam. Purification by silica column chromatography (10% MeOH in CH 2 Cl 2 ) gave a light yellow foam (7.80 g, 21.6 mmol, 51%); R f (C), 0.40; δ H (d 6 
F. 2-Amino-5-(3-Benzoyloxypropyl)-3,7-Dihydropyrrolo[ 2,3-d]Pyrimidin-4-One (9)
Thiophenol (3.83 g, 35.2 mmol) and triethylamine (3.61 g, 35.2 mmol) were added to a solution of tin (II) chloride dihydrate (2.22 g, 11.7 mmol) in MeCN (10 mL) and water (10 mL). The reaction was stirred for 10 min at room temp, then a solution of compound 8 (16.00 g, 44.3 mmol) in MeCN (10 mL) was added. The mixture was then stirred for 30 min., then a solution of tin (II) chloride dihydrate (1.63 g, 8.6 mmol), L-tartaric acid (5.90 g, 39.0 mmol) and sodium hydrogen carbonate (4.58 g, 54.6 mmol) in water (15 mL) was added in one portion, followed by a solution of sodium hydrogen sulfite (4.06 g, 39.0 mmol) in water (10 mL). The reaction mixture was then heated to 40ºC for 3 h, cooled to room temp, then poured into a 1:1 mixture of 2M aq HCl solution (30 mL) and ethyl acetate (30 mL) at 0ºC. The mixture was then neutralised with 10% aq ammonia solution then filtered and the ethyl acetate layer was then washed with water, dried (Na 2 SO 4 ) and evaporated. The residue was purified by silica column chromatography (0-10% MeOH/CH 2 Cl 2 ) to give a white solid (6.90 g, 50%); R f (C), 0.40; δ H (d 6 
G. 2-Amino-5-(3-Hydroxypropyl)-3,7-Dihydropyrrolo[2, 3-d]Pyrimidin-4-One (10)
Compound 9 (5.00 g, 15.9 mmol) was added to a solution of NaOH (2.00 g, 31.9 mmol) in water (20 mL) and reflux at 50˚C for 3 hrs. The precipitated compound was filtered and washes on filter paper with water (3.00 g, 63%); R f (C), 0.40; δ H (d 6 [2, 3-d] Pyrimidine (11) Compound 10 (1.00 g, 4.8 mmol) was suspended in phosphoryl chloride (7 ml) and the solution was heated at reflux overnight at 50 o C. The solution was allowed to cool and poured on to the crushed ice (30 mL), stir for 10 min. and then neutralized to pH 7 with conc. aqueous ammonia. It was left for 10 min. in an ice-bath and then filtered. Attempt to purify the compound on the silica column chromatography (10% MeOH/DCM) afford the compound in pure form as pale yellow solid (200 mg, 20%); [2,3- He roused from the rank of a graduate assistant in 2000 to a rank of assistant professor in 2012 at Bayero Universitry Kano Nigeria. His major research interest is on the studies of the synthesis of some modified nucleosides analogue of methyl-2'-deoxyguanosine as well as their incorporation into synthetic oligomers for AGT inactivation.
H. 2-Amino-5-(3-Chloropropyl)-4-Chloro-7H-Pyrrolo
R f (C),
I. 2-Amino-5-(3-Chloropropyl)-7-[2'-Deoxy-3,5-di-O-(pToluoyl)-β-D-Erythro-Pentofuranosyl]-4-Chloro-7H-Pyrr olo
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